Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
about
Brain tumorsGlioblastoma multiforme: emerging treatments and stratification markers beyond new drugsFunctional brain imaging: an evidence-based analysisComparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.Hypofractionated high-dose irradiation with positron emission tomography data for the treatment of glioblastoma multiforme.Imaging biomarkers in primary brain tumours.Imaging in neurooncologyHuman gene therapy and imaging in neurological diseases.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.[11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected 11C-methionine uptake.Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.Imaging biomarkers of brain tumour margin and tumour invasionSpecific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patientsFrom the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastomaImpact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PETEarly [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and HistopathologyPrognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.Clinical target volume delineation in glioblastomas: pre-operative versus post-operative/pre-radiotherapy MRI.Advances in neuro-oncology imaging.Positron emission tomography: clinical applications in oncology. Part 2.Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlatesFrom anatomical to biological target volumes: the role of PET in radiation treatment planningRelapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.The role of PET in target localization for radiotherapy treatment planning.Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomographyDifferentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.Diffuse brainstem gliomas in children: should we or shouldn't we biopsy?Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.Microfluidics for positron emission tomography probe development.Usefulness of FMISO-PET for glioma analysis.Novel positron emission tomography radiotracers in brain tumor imaging.
P2860
Q24605136-5C966262-1D3C-44BE-ACF0-3476FB081558Q28082603-FF14F94E-D86F-4681-A8DB-ABE445B59DBDQ30573784-31A39B7B-5D07-4D09-B3C1-8F8FA21286ABQ30811922-E1486013-A3BD-46ED-96C6-EEC851E76D11Q30834011-04C17534-1E3F-47F6-BC0F-1CEC3A1853CAQ30880129-309CBBF1-C454-48FE-B3D3-51D875AD7F7DQ30989939-DBC27F08-A3F4-462B-A2D4-30A7C6FA20EBQ31023442-22DDE493-8D47-4078-B66F-5C71060430FDQ33578187-84D8B49C-D51D-4FAB-8A95-720A086B0D52Q33599162-2CA8FE97-A483-47EE-87E8-124CC1E083A9Q33719890-EF7C903D-CC98-4CF3-A901-043EA4E6A0AAQ34136061-F1010B55-4856-486C-814E-A81FFF94B67DQ34203946-790A7771-0404-4D1E-AE69-EE655703A1C7Q34203953-B94793EA-A53C-447E-B101-728A856759D2Q34203960-D598F081-F37B-4606-8BAD-F352BCDFE2DAQ34533978-57B71CBB-A4A2-4180-8F84-B3E623D4B353Q35679377-46C96A9A-BD20-426B-B007-832BE8A0413CQ35699156-7320F483-B2A0-45B9-AD17-76E96A9439B7Q35788602-16A1448A-9AD8-4EE1-BB14-FC1B7373B29DQ35807945-C9C8989A-4D57-405A-86F8-73CBA3A3728BQ35821500-7C11F5E2-307E-4874-959C-52D8AB200A5FQ35835743-E9D20713-88F5-491B-ABC6-6C70080E235AQ35912078-050A2470-3ACF-4915-8136-F79C1F31246AQ36325371-DA5D5C57-AF5B-4B66-B9CC-2E76A86EDB9AQ36339461-BC8727A0-9C38-4546-AD88-57DE1A7CD923Q36448703-502409E5-D186-4421-8077-C265CD8ED213Q36644371-7CB5985C-AD4A-4205-90FE-58C3BBB5830CQ36657385-344848EC-1A48-4C2A-B610-89DC17EAF371Q37037922-C58127C9-2596-4EC4-8CA8-50F25F664542Q37082395-9A191A3E-D7C9-4E5C-BF00-F73E1C19DC4AQ37092483-16829ACA-4F7B-4D80-89DE-A7B0F7F709F2Q37235829-F29D7E9F-8FE9-4ECC-8A30-1103A9CE217DQ37244302-7BCC967E-16E4-41CF-A4B8-0702B4DE702DQ37328146-520DD3C8-0D8C-4FCE-9525-E4A3E7DB81D9Q37432387-85A823CC-2C4E-40EE-A461-DB15C065E955Q37469178-42C2EC14-67AE-4E5C-835B-DDFD52823185Q37614748-64A365B1-A523-4E29-A977-50C059D1F9F0Q37774061-613B1FE8-639A-450E-BFBF-E798DA056FF1Q38156537-6C5F07D8-7F4D-4182-ACA0-98E3224D12B1Q38670632-E708ABFE-D463-44D0-99E8-37E182F6FEB1
P2860
Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Delineation of brain tumor ext ...... h stereotactic histopathology.
@en
Delineation of brain tumor ext ...... h stereotactic histopathology.
@nl
type
label
Delineation of brain tumor ext ...... h stereotactic histopathology.
@en
Delineation of brain tumor ext ...... h stereotactic histopathology.
@nl
prefLabel
Delineation of brain tumor ext ...... h stereotactic histopathology.
@en
Delineation of brain tumor ext ...... h stereotactic histopathology.
@nl
P2093
P1476
Delineation of brain tumor ext ...... h stereotactic histopathology.
@en
P2093
Andreas H Jacobs
Hrvoje Miletic
Johannes C Klein
Jurgen Voges
Karl Herholz
Lutz W Kracht
Moritz Hoevels
Susanne Busch
Wolf-D Heiss
P304
P356
10.1158/1078-0432.CCR-04-0262
P407
P577
2004-11-01T00:00:00Z